Patent · US Expired

COMBINATION OF PROSTACYCLIN WITH AN ESTROGEN OR PROGESTIN FOR THE PREVENTION AND TREATMENT OF ATHEROSCLEROTIC VASCULAR DISEASE INCLUDING PREECLAMPSIA AND FOR THE TREATMENT OF HYPERTENSION, AND FOR HORMONE REPLACEMENT THERAPY

US6613757B1 · kind B1 · utility

7Cited by
1References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 22, 1994
Grant dateSep 2, 2003
Priority date
Expiry dateSep 22, 2014

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P15/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Cardiovascular disease, including preeclampsia in pregnant women and hypertension in both women and men, are prevented or treated by administering thereto prostacyclin or a prostacyclin analog in combination with one or both of an estrogen and a progestin, which combination is also useful for HRT in peri- and post-menopausal women.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.